After 30 years, eye movement desensitization and reprocessing (EMDR) therapy continues to gain support as a beneficial treatment for a wide range of mental health conditions, especially post-traumatic stress disorder.
Based on improved symptoms measured by the 6-item Hamilton Depression Rating Scale, SSRIs appear to be as effective in patients with nonsevere depression as in patients with severe depression.
Riluzole was overall well tolerated and associated with nonsignificant but positive effects in multiple psychiatric disorders, including depression and obsessive-compulsive disorder.
Based on their findings, the authors concluded that further research is needed to better understand the long term effects of CAM therapy for depression.
Despite a high prevalence of depressive symptoms, black and Hispanic patients with type 2 diabetes are significantly less likely to receive antidepressants compared with white patients.
Riluzole may be linked with a maintained response to acute treatment and improved response posttreatment in patients who had not responded immediately to acute-phase treatment.
